Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
Out-licensing Search
Search the Pharmalicensing out-licensing directory by keyword. Alternatively our advanced search allows you to query by industry sector, therapeutic target and development phase.
Most Viewed
Each Dose of Neo-Penotran® contains a combination of Metronidazole and Miconazole Nitrate in therapeutic concentrations for the local treatment of the treatment three main types of vaginal infections and mixed forms of vaginitis. More
New cream formulation to manage the symptoms of atopic dermatitis. More
We are seeking to out-license our product portfolio to territories where we do not have sales and marketing operations More
Collagen-based dressings for wound management More
25 and 50 mg diclofenac K film coated immediate release tablets More
Recently Added
UR-1505 is being developed for the topical treatment of psoriasis and atopic dermatitis More
The molecule is an azo derivative of an active molecule (UR-12715, PAF antagonist and anti-TNFa) and 5-aminosalicylic acid (5-ASA), the gold standard treatment for mild to moderate ulcerative colitis More
L-histidine is being developed as a prescription drug and as a dietary supplement for 1) chronic inflammatory gastrointestinal diseases; 2) conjunctivitis and seasonal allergic rhinitis; 3) infectious and non-infectious diarrheas; and 4) as an antioxidant More
Natural, antibacterial, anti-fungal, cleaning, hydrating, healing & analgesic drug More
1st drug in the world with dual & opposite activities of inhibiting the growth of microbial cells and simultaneously stimulating the healing process More
Help & Support
Find out how to use this section.
View the presentation.
View the presentation.
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
In the Spotlight...
Chemeq Technologies
Chemeq Technologies Pty Ltd is an innovative research company offering a unique antimicrobial polymer which provides a safe and effective alternative to antibiotics and conventional antimicrobials for human healthcare
The company's unique class-leading technology which is protected by seven major worldwide international patents has a wide application for therapeutic purposes for both topical and gastrointestinal indications
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us